CD4 and neoplasm: To further determine how Notch1 affected the antitumor immunity, B16-shNotch1 or B16-shCon cells were subcutaneously inoculated into C57BL/6 mice that were depleted of CD4+ or CD8+ T cells or NK cells and tumor growth was monitored.